img

Global Daclatasvir Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Daclatasvir Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Daclatasvir report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Daclatasvir market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hepatitis C Virus (HCV) Genotype 1 and Hepatitis C Virus (HCV) Genotype 3 are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Daclatasvir industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Daclatasvir key manufacturers include Bristol-Myers Squibb, Natco Pharma, Zydus Cadila, Hetero Drugs, Dr Reddy's Laboratories, Cipla, Mylan, Abbott and Emcure Pharmaceuticals, etc. Bristol-Myers Squibb, Natco Pharma, Zydus Cadila are top 3 players and held % sales share in total in 2022.
Daclatasvir can be divided into 30mg Tables and 60mg Tables, etc. 30mg Tables is the mainstream product in the market, accounting for % sales share globally in 2022.
Daclatasvir is widely used in various fields, such as Hepatitis C Virus (HCV) Genotype 1, Hepatitis C Virus (HCV) Genotype 3 and Hepatitis C Virus (HCV) Genotype 4,, etc. Hepatitis C Virus (HCV) Genotype 1 provides greatest supports to the Daclatasvir industry development. In 2022, global % sales of Daclatasvir went into Hepatitis C Virus (HCV) Genotype 1 filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Daclatasvir market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol-Myers Squibb
Natco Pharma
Zydus Cadila
Hetero Drugs
Dr Reddy's Laboratories
Cipla
Mylan
Abbott
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Biocon
Segment by Type
30mg Tables
60mg Tables

Segment by Application


Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Daclatasvir market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Daclatasvir, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Daclatasvir industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Daclatasvir in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Daclatasvir introduction, etc. Daclatasvir Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Daclatasvir market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Daclatasvir Market Overview
1.1 Daclatasvir Product Overview
1.2 Daclatasvir Market Segment by Type
1.2.1 30mg Tables
1.2.2 60mg Tables
1.3 Global Daclatasvir Market Size by Type
1.3.1 Global Daclatasvir Market Size Overview by Type (2018-2034)
1.3.2 Global Daclatasvir Historic Market Size Review by Type (2018-2024)
1.3.3 Global Daclatasvir Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Daclatasvir Sales Breakdown by Type (2018-2024)
1.4.2 Europe Daclatasvir Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Daclatasvir Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Daclatasvir Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Daclatasvir Sales Breakdown by Type (2018-2024)
2 Global Daclatasvir Market Competition by Company
2.1 Global Top Players by Daclatasvir Sales (2018-2024)
2.2 Global Top Players by Daclatasvir Revenue (2018-2024)
2.3 Global Top Players by Daclatasvir Price (2018-2024)
2.4 Global Top Manufacturers Daclatasvir Manufacturing Base Distribution, Sales Area, Product Type
2.5 Daclatasvir Market Competitive Situation and Trends
2.5.1 Daclatasvir Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Daclatasvir Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daclatasvir as of 2022)
2.7 Date of Key Manufacturers Enter into Daclatasvir Market
2.8 Key Manufacturers Daclatasvir Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Daclatasvir Status and Outlook by Region
3.1 Global Daclatasvir Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Daclatasvir Historic Market Size by Region
3.2.1 Global Daclatasvir Sales in Volume by Region (2018-2024)
3.2.2 Global Daclatasvir Sales in Value by Region (2018-2024)
3.2.3 Global Daclatasvir Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Daclatasvir Forecasted Market Size by Region
3.3.1 Global Daclatasvir Sales in Volume by Region (2024-2034)
3.3.2 Global Daclatasvir Sales in Value by Region (2024-2034)
3.3.3 Global Daclatasvir Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Daclatasvir by Application
4.1 Daclatasvir Market Segment by Application
4.1.1 Hepatitis C Virus (HCV) Genotype 1
4.1.2 Hepatitis C Virus (HCV) Genotype 3
4.1.3 Hepatitis C Virus (HCV) Genotype 4
4.2 Global Daclatasvir Market Size by Application
4.2.1 Global Daclatasvir Market Size Overview by Application (2018-2034)
4.2.2 Global Daclatasvir Historic Market Size Review by Application (2018-2024)
4.2.3 Global Daclatasvir Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Daclatasvir Sales Breakdown by Application (2018-2024)
4.3.2 Europe Daclatasvir Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Daclatasvir Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Daclatasvir Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Daclatasvir Sales Breakdown by Application (2018-2024)
5 North America Daclatasvir by Country
5.1 North America Daclatasvir Historic Market Size by Country
5.1.1 North America Daclatasvir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Daclatasvir Sales in Volume by Country (2018-2024)
5.1.3 North America Daclatasvir Sales in Value by Country (2018-2024)
5.2 North America Daclatasvir Forecasted Market Size by Country
5.2.1 North America Daclatasvir Sales in Volume by Country (2024-2034)
5.2.2 North America Daclatasvir Sales in Value by Country (2024-2034)
6 Europe Daclatasvir by Country
6.1 Europe Daclatasvir Historic Market Size by Country
6.1.1 Europe Daclatasvir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Daclatasvir Sales in Volume by Country (2018-2024)
6.1.3 Europe Daclatasvir Sales in Value by Country (2018-2024)
6.2 Europe Daclatasvir Forecasted Market Size by Country
6.2.1 Europe Daclatasvir Sales in Volume by Country (2024-2034)
6.2.2 Europe Daclatasvir Sales in Value by Country (2024-2034)
7 Asia-Pacific Daclatasvir by Region
7.1 Asia-Pacific Daclatasvir Historic Market Size by Region
7.1.1 Asia-Pacific Daclatasvir Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Daclatasvir Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Daclatasvir Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Daclatasvir Forecasted Market Size by Region
7.2.1 Asia-Pacific Daclatasvir Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Daclatasvir Sales in Value by Region (2024-2034)
8 Latin America Daclatasvir by Country
8.1 Latin America Daclatasvir Historic Market Size by Country
8.1.1 Latin America Daclatasvir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Daclatasvir Sales in Volume by Country (2018-2024)
8.1.3 Latin America Daclatasvir Sales in Value by Country (2018-2024)
8.2 Latin America Daclatasvir Forecasted Market Size by Country
8.2.1 Latin America Daclatasvir Sales in Volume by Country (2024-2034)
8.2.2 Latin America Daclatasvir Sales in Value by Country (2024-2034)
9 Middle East and Africa Daclatasvir by Country
9.1 Middle East and Africa Daclatasvir Historic Market Size by Country
9.1.1 Middle East and Africa Daclatasvir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Daclatasvir Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Daclatasvir Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Daclatasvir Forecasted Market Size by Country
9.2.1 Middle East and Africa Daclatasvir Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Daclatasvir Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bristol-Myers Squibb Daclatasvir Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Natco Pharma
10.2.1 Natco Pharma Company Information
10.2.2 Natco Pharma Introduction and Business Overview
10.2.3 Natco Pharma Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Natco Pharma Daclatasvir Products Offered
10.2.5 Natco Pharma Recent Development
10.3 Zydus Cadila
10.3.1 Zydus Cadila Company Information
10.3.2 Zydus Cadila Introduction and Business Overview
10.3.3 Zydus Cadila Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Zydus Cadila Daclatasvir Products Offered
10.3.5 Zydus Cadila Recent Development
10.4 Hetero Drugs
10.4.1 Hetero Drugs Company Information
10.4.2 Hetero Drugs Introduction and Business Overview
10.4.3 Hetero Drugs Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hetero Drugs Daclatasvir Products Offered
10.4.5 Hetero Drugs Recent Development
10.5 Dr Reddy's Laboratories
10.5.1 Dr Reddy's Laboratories Company Information
10.5.2 Dr Reddy's Laboratories Introduction and Business Overview
10.5.3 Dr Reddy's Laboratories Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Dr Reddy's Laboratories Daclatasvir Products Offered
10.5.5 Dr Reddy's Laboratories Recent Development
10.6 Cipla
10.6.1 Cipla Company Information
10.6.2 Cipla Introduction and Business Overview
10.6.3 Cipla Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cipla Daclatasvir Products Offered
10.6.5 Cipla Recent Development
10.7 Mylan
10.7.1 Mylan Company Information
10.7.2 Mylan Introduction and Business Overview
10.7.3 Mylan Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Mylan Daclatasvir Products Offered
10.7.5 Mylan Recent Development
10.8 Abbott
10.8.1 Abbott Company Information
10.8.2 Abbott Introduction and Business Overview
10.8.3 Abbott Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Abbott Daclatasvir Products Offered
10.8.5 Abbott Recent Development
10.9 Emcure Pharmaceuticals
10.9.1 Emcure Pharmaceuticals Company Information
10.9.2 Emcure Pharmaceuticals Introduction and Business Overview
10.9.3 Emcure Pharmaceuticals Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Emcure Pharmaceuticals Daclatasvir Products Offered
10.9.5 Emcure Pharmaceuticals Recent Development
10.10 Torrent Pharmaceuticals
10.10.1 Torrent Pharmaceuticals Company Information
10.10.2 Torrent Pharmaceuticals Introduction and Business Overview
10.10.3 Torrent Pharmaceuticals Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Torrent Pharmaceuticals Daclatasvir Products Offered
10.10.5 Torrent Pharmaceuticals Recent Development
10.11 Biocon
10.11.1 Biocon Company Information
10.11.2 Biocon Introduction and Business Overview
10.11.3 Biocon Daclatasvir Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Biocon Daclatasvir Products Offered
10.11.5 Biocon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Daclatasvir Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Daclatasvir Industrial Chain Analysis
11.4 Daclatasvir Market Dynamics
11.4.1 Daclatasvir Industry Trends
11.4.2 Daclatasvir Market Drivers
11.4.3 Daclatasvir Market Challenges
11.4.4 Daclatasvir Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Daclatasvir Distributors
12.3 Daclatasvir Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 30mg Tables
Table 2. Major Company of 60mg Tables
Table 3. Global Daclatasvir Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Daclatasvir Sales by Type (2018-2024) & (K Pcs)
Table 5. Global Daclatasvir Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Daclatasvir Sales by Type (2018-2024) & (US& Million)
Table 7. Global Daclatasvir Market Share in Value by Type (2018-2024)
Table 8. Global Daclatasvir Price by Type (2018-2024) & (USD/Pcs)
Table 9. Global Daclatasvir Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Daclatasvir Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Daclatasvir Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Daclatasvir Sales Market Share in Value by Type (2024-2034)
Table 13. Global Daclatasvir Price by Type (2024-2034) & (USD/Pcs)
Table 14. North America Daclatasvir Sales by Type (2018-2024) & (K Pcs)
Table 15. North America Daclatasvir Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Daclatasvir Sales (K Pcs) by Type (2018-2024)
Table 17. Europe Daclatasvir Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Daclatasvir Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific Daclatasvir Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Daclatasvir Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America Daclatasvir Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Daclatasvir Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa Daclatasvir Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Daclatasvir Sales by Company (2018-2024) & (K Pcs)
Table 25. Global Daclatasvir Sales Share by Company (2018-2024)
Table 26. Global Daclatasvir Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Daclatasvir Revenue Share by Company (2018-2024)
Table 28. Global Market Daclatasvir Price by Company (2018-2024) & (USD/Pcs)
Table 29. Global Daclatasvir Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Daclatasvir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daclatasvir as of 2022)
Table 32. Date of Key Manufacturers Enter into Daclatasvir Market
Table 33. Key Manufacturers Daclatasvir Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Daclatasvir Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Daclatasvir Sales by Region (2018-2024) & (K Pcs)
Table 37. Global Daclatasvir Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Daclatasvir Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Daclatasvir Sales Market Share in Value by Region (2018-2024)
Table 40. Global Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 41. Global Daclatasvir Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Daclatasvir Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Daclatasvir Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Daclatasvir Sales Market Share in Value by Region (2024-2034)
Table 45. Global Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 46. Global Daclatasvir Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Daclatasvir Sales by Application (2018-2024) & (K Pcs)
Table 48. Global Daclatasvir Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Daclatasvir Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Daclatasvir Sales Market Share in Value by Application (2018-2024)
Table 51. Global Daclatasvir Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Daclatasvir Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Daclatasvir Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Daclatasvir Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Daclatasvir Sales Market Share in Value by Application (2024-2034)
Table 56. Global Daclatasvir Price by Application (2024-2034) & (USD/Pcs)
Table 57. North America Daclatasvir Sales by Application (2018-2024) (K Pcs)
Table 58. North America Daclatasvir Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Daclatasvir Sales by Application (2018-2024) (K Pcs)
Table 60. Europe Daclatasvir Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Daclatasvir Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific Daclatasvir Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Daclatasvir Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America Daclatasvir Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Daclatasvir Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa Daclatasvir Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Daclatasvir Sales by Country (2018-2024) & (K Pcs)
Table 68. North America Daclatasvir Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Daclatasvir Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Daclatasvir Sales Market Share in Value by Country (2018-2024)
Table 71. North America Daclatasvir Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Daclatasvir Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Daclatasvir Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Daclatasvir Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Daclatasvir Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe Daclatasvir Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Daclatasvir Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Daclatasvir Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Daclatasvir Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Daclatasvir Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Daclatasvir Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Daclatasvir Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Daclatasvir Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific Daclatasvir Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Daclatasvir Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Daclatasvir Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Daclatasvir Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Daclatasvir Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Daclatasvir Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Daclatasvir Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Daclatasvir Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America Daclatasvir Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Daclatasvir Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Daclatasvir Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Daclatasvir Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Daclatasvir Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Daclatasvir Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Daclatasvir Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Daclatasvir Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa Daclatasvir Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Daclatasvir Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Daclatasvir Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Daclatasvir Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Daclatasvir Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Daclatasvir Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Daclatasvir Sales Market Share in Value by Country (2024-2034)
Table 107. Bristol-Myers Squibb Company Information
Table 108. Bristol-Myers Squibb Introduction and Business Overview
Table 109. Bristol-Myers Squibb Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Bristol-Myers Squibb Daclatasvir Product
Table 111. Bristol-Myers Squibb Recent Development
Table 112. Natco Pharma Company Information
Table 113. Natco Pharma Introduction and Business Overview
Table 114. Natco Pharma Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Natco Pharma Daclatasvir Product
Table 116. Natco Pharma Recent Development
Table 117. Zydus Cadila Company Information
Table 118. Zydus Cadila Introduction and Business Overview
Table 119. Zydus Cadila Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Zydus Cadila Daclatasvir Product
Table 121. Zydus Cadila Recent Development
Table 122. Hetero Drugs Company Information
Table 123. Hetero Drugs Introduction and Business Overview
Table 124. Hetero Drugs Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Hetero Drugs Daclatasvir Product
Table 126. Hetero Drugs Recent Development
Table 127. Dr Reddy's Laboratories Company Information
Table 128. Dr Reddy's Laboratories Introduction and Business Overview
Table 129. Dr Reddy's Laboratories Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Dr Reddy's Laboratories Daclatasvir Product
Table 131. Dr Reddy's Laboratories Recent Development
Table 132. Cipla Company Information
Table 133. Cipla Introduction and Business Overview
Table 134. Cipla Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Cipla Daclatasvir Product
Table 136. Cipla Recent Development
Table 137. Mylan Company Information
Table 138. Mylan Introduction and Business Overview
Table 139. Mylan Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Mylan Daclatasvir Product
Table 141. Mylan Recent Development
Table 142. Abbott Company Information
Table 143. Abbott Introduction and Business Overview
Table 144. Abbott Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Abbott Daclatasvir Product
Table 146. Abbott Recent Development
Table 147. Emcure Pharmaceuticals Company Information
Table 148. Emcure Pharmaceuticals Introduction and Business Overview
Table 149. Emcure Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Emcure Pharmaceuticals Daclatasvir Product
Table 151. Emcure Pharmaceuticals Recent Development
Table 152. Torrent Pharmaceuticals Company Information
Table 153. Torrent Pharmaceuticals Introduction and Business Overview
Table 154. Torrent Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Torrent Pharmaceuticals Daclatasvir Product
Table 156. Torrent Pharmaceuticals Recent Development
Table 157. Biocon Company Information
Table 158. Biocon Introduction and Business Overview
Table 159. Biocon Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Biocon Daclatasvir Product
Table 161. Biocon Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Daclatasvir Market Trends
Table 165. Daclatasvir Market Drivers
Table 166. Daclatasvir Market Challenges
Table 167. Daclatasvir Market Restraints
Table 168. Daclatasvir Distributors List
Table 169. Daclatasvir Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Daclatasvir Product Picture
Figure 2. Global Daclatasvir Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Daclatasvir Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Daclatasvir Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of 30mg Tables
Figure 6. Global 30mg Tables Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of 60mg Tables
Figure 8. Global 60mg Tables Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Global Daclatasvir Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Daclatasvir Sales Market Share by Type in 2022 & 2034
Figure 11. North America Daclatasvir Sales Market Share in Volume by Type in 2022
Figure 12. North America Daclatasvir Sales Market Share in Value by Type in 2022
Figure 13. Europe Daclatasvir Sales Market Share in Volume by Type in 2022
Figure 14. Europe Daclatasvir Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Daclatasvir Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Daclatasvir Sales Market Share in Value by Type in 2022
Figure 17. Latin America Daclatasvir Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Daclatasvir Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Daclatasvir Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Daclatasvir Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Daclatasvir Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Daclatasvir Revenue in 2022
Figure 23. Daclatasvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hepatitis C Virus (HCV) Genotype 1
Figure 25. Global Hepatitis C Virus (HCV) Genotype 1 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 26. Product Picture of Hepatitis C Virus (HCV) Genotype 3
Figure 27. Global Hepatitis C Virus (HCV) Genotype 3 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Hepatitis C Virus (HCV) Genotype 4
Figure 29. Global Hepatitis C Virus (HCV) Genotype 4 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Global Daclatasvir Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Daclatasvir Sales Market Share by Application in 2022 & 2034
Figure 32. North America Daclatasvir Sales Market Share in Volume by Application in 2022
Figure 33. North America Daclatasvir Sales Market Share in Value by Application in 2022
Figure 34. Europe Daclatasvir Sales Market Share in Volume by Application in 2022
Figure 35. Europe Daclatasvir Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Daclatasvir Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Daclatasvir Sales Market Share in Value by Application in 2022
Figure 38. Latin America Daclatasvir Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Daclatasvir Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Daclatasvir Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Daclatasvir Manufacturing Cost Structure
Figure 43. Daclatasvir Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries